Inez is a pharmaceutical professional with a broad network across pharmaceutical and biotechnology companies worldwide. As partner and co-founder of 3D-PharmXchange she is responsible for the strategy and management of 3D-PharmXchange.
Inez has been involved in a diverse pallet of drug development projects with a focus on clinical development. Her in-depth knowledge of the different elements of drug development and the interfaces between them are of great value to our clients. In 2013 she was appointed as CEO for our client Treeway, a biotechnology company with a mission to develop therapies to cure ALS.
Prior founding 3D-PharmXchange, she was subsequently Director Clinical Development and Chief Operating Officer of Kinesis Pharma. She also worked several years as consultant and project manager on clinical and PK-PD projects in several therapeutic areas.
At Tibotec-Virco, she managed the clinical pharmacology program for their successfully approved HIV protease inhibitor Prezistra and follow-up compounds. At Leiden Advanced Experts on PK and PD (LAP&P) she was responsible for modeling & simulation projects and project management.
Inez studied Medical Biology at the University of Amsterdam, The Netherlands, and obtained her PhD at the department of Pharmacology from the LACDR at Leiden University, The Netherlands.